2024 Fall Conference | C22 - Clinical Trials Update
Program Materials Program Evaluations
03:00 PM - 03:30 PM PDT | Speaker |
The Current State of Long-COVID: Clinical Trials and Ethical Aspects
Avindra Nath, MD, MBBS, FAAN |
03:30 PM - 04:00 PM PDT | Speaker |
Gene Transfer Therapy: Is it Safe?
Julie A. Parsons, MD |
04:00 PM - 04:30 PM PDT | Speaker |
Migraine Management in Special Populations
Eric Kaiser, MD, PhD |
Avindra Nath, MD, MBBS, FAAN | The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care. |
Eric Kaiser, MD, PhD | The institution of Dr. Kaiser has received research support from Amgen. Dr. Kaiser has received intellectual property interests from a discovery or technology relating to health care. |
Julie A. Parsons, MD | Dr. Parsons has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenex. The institution of Dr. Parsons has received research support from AveXis. The institution of Dr. Parsons has received research support from Biogen. The institution of Dr. Parsons has received research support from Scholar Rock. The institution of Dr. Parsons has received research support from Biohaven. The institution of Dr. Parsons has received research support from PTC Therapeutics. The institution of Dr. Parsons has received research support from Novartis. |
Marcelo Matiello, MD, FAAN | Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. |